Zimmer Biomet Holdings, Inc. finalized its merger with Monogram Technologies, Inc. on October 7, 2025, converting Monogram shareholders' stocks into cash amounts of $4.04 for common stock and other specified values for preferred stocks. This event follows a previously reported merger agreement initiated on July 11, 2025.